[HTML][HTML] Cell-penetrating peptides in protein mimicry and cancer therapeutics

M Zorko, S Jones, Ü Langel - Advanced drug delivery reviews, 2022 - Elsevier
Extensive research has been undertaken in the pursuit of anticancer therapeutics. Many
anticancer drugs require specificity of delivery to cancer cells, whilst sparing healthy tissue …

Src: coordinating metabolism in cancer

SG Pelaz, A Tabernero - Oncogene, 2022 - nature.com
Metabolism must be tightly regulated to fulfil the dynamic requirements of cancer cells during
proliferation, migration, stemness and differentiation. Src is a node of several signals …

Combination of cell-penetrating peptides with nanomaterials for the potential therapeutics of central nervous system disorders: a review

Y Zhang, P Guo, Z Ma, P Lu, D Kebebe… - Journal of …, 2021 - Springer
Although nanomedicine have greatly developed and human life span has been extended,
we have witnessed the soared incidence of central nervous system (CNS) diseases …

Status update in the use of cell-penetrating peptides for the delivery of macromolecular therapeutics

K Kurrikoff, B Vunk, Ü Langel - Expert Opinion on Biological …, 2021 - Taylor & Francis
Introduction In this review, recent developments and applications with cell-penetrating
peptides (CPP) are discussed. CPPs are widely used tools for the delivery of various …

Targeting connexin 43 provides anti-inflammatory effects after intracerebral hemorrhage injury by regulating YAP signaling

H Yu, X Cao, W Li, P Liu, Y Zhao, L Song… - Journal of …, 2020 - Springer
Background In the central nervous system (CNS), connexin 43 (Cx43) is mainly expressed
in astrocytes and regulates astrocytic network homeostasis. Similar to Cx43 overexpression …

Cell-penetrating peptides in oncologic pharmacotherapy: A review

N Vale, D Duarte, S Silva, AS Correia, B Costa… - Pharmacological …, 2020 - Elsevier
Cancer is the second leading cause of death in the world and its treatment is extremely
challenging, mainly due to its complexity. Cell-Penetrating Peptides (CPPs) are peptides …

Targeting metabolic plasticity in glioma stem cells in vitro and in vivo through specific inhibition of c-Src by TAT-Cx43266-283

SG Pelaz, M Jaraíz-Rodríguez, A Álvarez-Vázquez… - …, 2020 - thelancet.com
Background Glioblastoma is the most aggressive primary brain tumour and has a very poor
prognosis. Inhibition of c-Src activity in glioblastoma stem cells (GSCs, responsible for …

Ligand-modified homologous targeted cancer cell membrane biomimetic nanostructured lipid carriers for glioma therapy

M Chen, Y Cui, W Hao, Y Fan, J Zhang, Q Liu… - Drug Delivery, 2021 - Taylor & Francis
The main treatment measure currently used for glioma treatment is chemotherapy; the
biological barrier of solid tumors hinders the deep penetration of nanomedicines and limits …

Glioma‑neuronal interactions in tumor progression: Mechanism, therapeutic strategies and perspectives

T Hua, H Shi, M Zhu, C Chen, Y Su… - International …, 2022 - spandidos-publications.com
An increasing body of evidence has become available to reveal the synaptic and functional
integration of glioma into the brain network, facilitating tumor progression. The novel …

The proto-oncogene tyrosine kinase c-SRC facilitates glioblastoma progression by remodeling fatty acid synthesis

W Zhao, C Ouyang, L Zhang, J Wang, J Zhang… - Nature …, 2024 - nature.com
Increased fatty acid synthesis benefits glioblastoma malignancy. However, the coordinated
regulation of cytosolic acetyl-CoA production, the exclusive substrate for fatty acid synthesis …